Beijing Friendship Hospital: Epstein-Barr Virus Infections trials

The registry lists 10 Epstein-Barr Virus Infections studies with Beijing Friendship Hospital as lead sponsor. 2 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 3 3No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study on Efficacy and Safety of iNK Cells for CAEBV /EBV-HLH After Allo-HSCTNot yet recruitingNCT06491719Not applicable
• Segmental Resection Combined With DEP Regimen for EBV-HLH Patients With Intestinal InvolvementNot yet recruitingNCT06131489
• Prospective Study of Immune Function and PD-1 Antibody Therapy Efficacy Predictors on CAEBV and EBV-HLH PatientsStatus unknownNCT05841342
• L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLHCompletedNCT05775705Not applicable
• Clinical Study of Donor EBV-CTL Infusion in Patients With CAEBV and EBV-HLH After Allo-HSCTStatus unknownNCT05532826Not applicable
• Rituximab Monotherapy for EBV-HLH and CAEBVStatus unknownNCT05384743Phase 3
• Study on the Application of Saliva EBV-DNA Detection in EBV Infection Related DiseasesStatus unknownNCT04782674
• PD-1 Antibody for Reactive EBV After BMTStatus unknownNCT04690036Early Phase 1
• PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBVStatus unknownNCT04084626Phase 3
• L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic LymphohistiocytosisStatus unknownNCT02631109Phase 3